FDAFDA · Food and drugs·Recall number D-1862-2019
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.
Published September 25, 2019 · Recall initiated: September 6, 2019
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ANAGRELIDE
- Manufacturer
- Torrent Pharma Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot #: BFE2E003, Exp 08/31/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.